FDA Fast-Tracked New Alzheimer’s Treatment to Mixed Reviews

Alzheimer’s is a debilitating brain disorder affecting memory and, eventually, language, reasoning, and social behavior. Diagnosed in nearly 6.2 million Americans, Alzheimer’s is a progressive, irreversible disease with treatments mainly focusing on symptoms, such as delaying memory loss, and not the underlying cause—that is, until now. In June of 2021—just in time for Alzheimer’s Awareness Month—the U.S. Food and Drug … Read More